白细胞介素-3可增强内源性白三烯的生成。 - Suppr | 超能文献

Interleukin-3 enhances the endogenous leukotriene production.

作者信息

Denzlinger C, Walther J, Wilmanns W, Gerhartz H H

出版信息

Blood. 1993 May 1;81(9):2466-8.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Interleukin-3 enhances the endogenous leukotriene production.白细胞介素-3可增强内源性白三烯的生成。

Blood. 1993 May 1;81(9):2466-8.

2

Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.异环磷酰胺、表柔比星和依托泊苷方案作为复发/难治性淋巴瘤患者的挽救和动员治疗。

Haematologica. 2002 Aug;87(8):816-21.

3

Therapeutic strategies in intermediate grade lymphomas in elderly patients. The Italian Multiregional non Hodgkin's Lymphoma Study Group (IMRNHLSG).老年患者中晚期淋巴瘤的治疗策略。意大利多区域非霍奇金淋巴瘤研究组（IMRNHLSG）。

Hematol Oncol. 1993;11 Suppl 1:52-8.

4

Ifosfamide, epirubicin and etoposide (IEV) in non-Hodgkin's lymphoma and Hodgkin's disease: the Italian experience.异环磷酰胺、表柔比星和依托泊苷（IEV）治疗非霍奇金淋巴瘤和霍奇金病：意大利的经验。

Ann Oncol. 2003;14 Suppl 1:i43-5. doi: 10.1093/annonc/mdg709.

5

Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study.重组人白细胞介素-11在实体瘤或淋巴瘤儿童、青少年及年轻成人中于异环磷酰胺、卡铂和依托泊苷之后的I/II期剂量递增研究：一项临床、血液学及生物学研究

Br J Haematol. 2005 Jan;128(1):49-58. doi: 10.1111/j.1365-2141.2004.05281.x.

6

Interleukin-3 enhances the endogenous leukotriene production.白细胞介素-3可增强内源性白三烯的产生。

Blood. 1993 Apr 1;81(7):1975-6.

7

Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV).使用异环磷酰胺、表柔比星和依托泊苷（IEV）在淋巴增殖性疾病中有效动员祖细胞。

Eur J Haematol Suppl. 2001 Jul;64:33-6.

8

Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphoma.异环磷酰胺、卡铂和依托泊苷联合用于诱导化疗和大剂量化疗：聚焦于乳腺癌和淋巴瘤。

Hematol Oncol. 1992 Jan-Feb;10(1):61-74. doi: 10.1002/hon.2900100111.

9

High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.大剂量异环磷酰胺联合依托泊苷和表柔比星（IVE方案）治疗复发/难治性霍奇金淋巴瘤和非霍奇金淋巴瘤：毒性和疗效报告

Eur J Haematol Suppl. 2001 Jul;64:28-32.

10

Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.异环磷酰胺、表柔比星、依托泊苷（IEV）与自体外周血祖细胞移植：一种治疗淋巴系统恶性肿瘤的可行且有效的挽救性疗法。

Oncol Rep. 2005 Oct;14(4):933-40.

引用本文的文献

1

Multiple conformations of a human interleukin-3 variant.一种人类白细胞介素-3变体的多种构象

Protein Sci. 1997 Aug;6(8):1777-82. doi: 10.1002/pro.5560060821.

2

Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3.与重组人白细胞介素3相比，具有选择性增强造血活性的强效白细胞介素3受体激动剂。

Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3779-83. doi: 10.1073/pnas.92.9.3779.